Company Filing History:
Years Active: 2022
Title: Innovations in Bladder Cancer Detection by Inventor Wanli Ren
Introduction
Wanli Ren, an innovative inventor based in Hangzhou, China, has made significant contributions to the field of medical technology. With one patent to his name, he is dedicated to improving cancer detection methods. His work, particularly focused on bladder cancer, stands at the forefront of medical research and diagnostics.
Latest Patents
Ren's notable patent is titled "Set of genes for bladder cancer detection and use thereof." This invention discloses a comprehensive set of 32 genes effective for detecting bladder cancer. The identified genes include CA9, CDK1, CTSE, and many others. Each gene plays a pivotal role in enhancing the accuracy of bladder cancer detection. Following clinical validation, the detection kit associated with this patent has demonstrated a high accuracy rate and offers an objective interpretation of results. This innovation presents a non-invasive alternative to traditional procedures such as cystoscopy, thereby improving patient compliance and contributing significantly to the early detection and monitoring of bladder cancer.
Career Highlights
Ren is associated with Hangzhou Canhelp Genomics Technology Co. Ltd., a company dedicated to advancing genomic technology and its application in healthcare. His tenure at this firm highlights his commitment to integrating science and technology in fighting cancer. Through rigorous research and development, Ren continues to push the boundaries of cancer diagnostics.
Collaborations
Throughout his career, Wanli Ren has worked alongside esteemed colleagues such as Qinghua Xu and Dingwei Ye. Their collaborative efforts reflect a team spirit aimed at leveraging genetic research to enhance diagnostic methodologies for cancer. Together, they harness their collective expertise to drive forward significant advancements in the field.
Conclusion
In summary, Wanli Ren stands as a pioneering force in the realm of cancer detection. His patent for a set of genes used in bladder cancer diagnosis is a testament to his innovative spirit and dedication to medical science. With ongoing collaborations and a strong commitment to research, he is poised to contribute even more to the future of cancer diagnostics and patient care.